Brief: Grand Pharmaceutical Posts HY Profit Attributable HK$1,169.02 Million
19/08/2025 15:53
Aug 19 (Reuters) - Grand Pharmaceutical Group Ltd 0512.HK: HY PROFIT ATTRIBUTABLE HK$1,169.02 MILLION HY REVENUE HK$6,107.32 MILLION Further company coverage: 0512.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement